Application of digital polymerase chain reaction technology for noninvasive prenatal test
Author(s) -
Sung Yong Lee,
Seung Yong Hwang
Publication year - 2015
Publication title -
journal of genetic medicine
Language(s) - English
Resource type - Journals
eISSN - 2233-9108
pISSN - 1226-1769
DOI - 10.5734/jgm.2015.12.2.72
Subject(s) - digital polymerase chain reaction , aneuploidy , cell free fetal dna , amniocentesis , prenatal diagnosis , polymerase chain reaction , trisomy , chorionic villus sampling , medicine , obstetrics , computational biology , fetus , biology , chromosome , genetics , pregnancy , gene
the chromosomal abnormalities, it was reported that Down syndrome (trisomy 21) occurs in 1 in 800 [3,4], Edward syndrome (trisomy 18) in 1 in 6,000 [5], and Patau syndrome (trisomy 13) in 1 in 10,000 fetal subjects [6]. Moreover, birth defects from Down syndrome comprise about 26% of all congenital birth defects [7,8]. As maternal age increases, fetal chromosomal aneuploidy becomes more prevalent [9]. The prevalence of fetal aneuploidy has rapidly increased over the last decade in Korea because of the increasing age of marriage and childbearing (Table 1). Application of digital polymerase chain reaction technology for noninvasive prenatal test
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom